Cyclacel Pharmaceuticals Inc. buy Roth Mkm
Start price
19.12.23
/
50%
€0.22
Target price
19.12.24
€19.12
Performance (%)
-
End price
20.12.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cyclacel Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Roth_Mkm for this prediction
In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target raised by analysts at Roth Mkm from $16.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CYCC provided by MarketBeat
In the thread Trading Cyclacel Pharmaceuticals Inc.
Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Roth_Mkm for Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.22
03.05.24
03.05.24
€10.21
03.05.25
03.05.25
-
04.05.25
04.05.25

